MedicaidCoverageMedium impact
Newsletter Vol. 13, No. 53
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
New Jersey Medicaid and NJ FamilyCare have removed certain manufacturers from their drug rebate program's approved labeler code list. This affects which pharmaceutical manufacturers are eligible for rebate programs, potentially impacting drug coverage and prior authorization requirements.
Action Required
Immediately: Billing team should review current pharmaceutical claims for New Jersey Medicaid and NJ FamilyCare patients to identify any drugs from manufacturers that may have been removed from the rebate program. Contact NJ Medicaid for updated prior authorization requirements or formulary changes that may result from these deletions. Monitor for potential claim denials or coverage changes for affected medications.